This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
To streamline complex medical writing workflows with GenAI
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
The study showed that sClever-1 is released by macrophages and blood vessel cells and binds to activated T cells
Extended lab space for product development, customer demos, and training
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Ranks among the top 15% companies globally
Subscribe To Our Newsletter & Stay Updated
